Esperion Therapeutics, Inc. (ESPR)

Esperion Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for ESPR stock have an average target of 9.33, with a low estimate of 4.00 and a high estimate of 16. The average target predicts an increase of 391.05% from the current stock price of 1.90.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$9.33	$8.00	$16
Change	+110.53%	+391.05%	+321.05%	+742.11%

Analyst Ratings

The average analyst rating for ESPR stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '23	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24
Strong Buy	3	3	3	3	3	3
Buy	1	1	1	1	0	0
Hold	3	3	3	3	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Serge Belanger Needham	Needham	Strong Buy Reiterates $8	Strong Buy	Reiterates	$8	+321.05%	Apr 10, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $16	Strong Buy	Reiterates	$16	+742.11%	Mar 25, 2024
Serge Belanger Needham	Needham	Strong Buy Reiterates $8	Strong Buy	Reiterates	$8	+321.05%	Mar 25, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $22 → $16	Strong Buy	Maintains	$22 → $16	+742.11%	Feb 28, 2024
Serge Belanger Needham	Needham	Strong Buy Reiterates $8	Strong Buy	Reiterates	$8	+321.05%	Feb 27, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

270.44M

Increased by 132.47%

from 116.33M

Revenue Next Year

398.85M

Increased by 47.48%

from 270.44M

EPS This Year

-0.41

from -2.03

EPS Next Year

0.05

from -0.41

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	148.36M	227.55M	78.45M	75.48M	116.33M	270.44M	398.85M	672.32M	798.15M	1.23B
Revenue Growth	-	53.37%	-65.52%	-3.79%	54.14%	132.47%	47.48%	68.56%	18.72%	53.73%
EPS	-3.59	-5.23	-9.31	-3.52	-2.03	-0.41	0.05	1.14	3.34	6.07
EPS Growth	-	-	-	-	-	-	-	2,054.69%	194.16%	81.83%
No. Analysts	-	-	-	-	-	10	8	5	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	344.6M	745.7M	1.1B	1.4B	2.3B
Avg	270.4M	398.9M	672.3M	798.2M	1.2B
Low	170.5M	260.8M	450.8M	474.3M	560.4M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	196.2%	175.7%	169.0%	105.4%	189.3%
Avg	132.5%	47.5%	68.6%	18.7%	53.7%
Low	46.6%	-3.6%	13.0%	-29.5%	-29.8%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	0.09	1.56	2.63	5.81	10.98
Avg	-0.41	0.05	1.14	3.34	6.07
Low	-0.98	-0.66	0.10	1.00	1.42

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-	-	4,880.7%	411.3%	228.8%
Avg	-	-	2,054.7%	194.2%	81.8%
Low	-	-	85.9%	-12.0%	-57.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.